Cart
sales@molnova.com
CPI-0610 carboxylic acid
CAS No. 1380089-81-5
CPI-0610 carboxylic acid( —— )
Catalog No. M32861 CAS No. 1380089-81-5
CPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 673 | In Stock |
|
| 10MG | 901 | In Stock |
|
| 25MG | 1311 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPI-0610 carboxylic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein.
-
DescriptionCPI-0610 carboxylic acid is an effective and selective small molecule inhibitor of bromine domain and outer end (BET) protein as a ligand of PROTAC target protein. CPI-0610 carboxylic acid may have anticancer and anticancer activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain | Ligands for Target Protein for PROTAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1380089-81-5
-
Formula Weight366.8
-
Molecular FormulaC20H15ClN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1C=2C=3C(C(=N[C@@H](CC(O)=O)C2ON1)C4=CC=C(Cl)C=C4)=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
SRX3177
SRX3177 is a novel and potent inhibitor of BRD4, PI3K and CDK.SRX3177 has potential anticancer activity.
-
ODM-207
BET-IN-4 is a potent BRD4 inhibitor.
-
BRD4?Inhibitor-27
BRD4?Inhibitor-27 is a potent BRD4 inhibitor that inhibits BRD4 BD1 and BRD4 BD2 with IC50s of 9.6 and 11.3 μM, respectively.BRD4?Inhibitor-27 has anticancer activity and can be used for breast cancer research.
